ASRT
Assertio Therapeutics Inc
NASDAQ: ASRT · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$18.43
+2.11% today
Updated 2026-04-30
Market cap
$116.45M
P/E ratio
—
P/S ratio
0.98x
EPS (TTM)
$-4.74
Dividend yield
—
52W range
$9 – $20
Volume
0.2M
Assertio Therapeutics Inc (ASRT) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$18.43
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$78.89
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.1B | $0.2B | $0.2B | $0.1B | $0.1B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -25.60%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.